Radiolabeled choline and prostate-specific membrane antigen (PSMA) positron emission tomography (PET), associated with computed tomography (CT) or MRI, may play important roles as diagnostic modalities in patients with PCa. The gene discussed is FOLH1; the disease is posterior cortical atrophy.